Shanghai Pharmaceuticals Holding Co., Ltd (FRA:S1R)

Germany flag Germany · Delayed Price · Currency is EUR
1.200
-0.020 (-1.64%)
At close: Mar 27, 2026
Market Cap7.01B -16.6%
Revenue (ttm)33.60B +3.0%
Net Income675.86M +40.2%
EPS0.18 +41.6%
Shares Outn/a
PE Ratio10.38
Forward PE11.11
Dividend0.05 (4.10%)
Ex-Dividend DateDec 29, 2025
Volumen/a
Average Volume27
Open1.240
Previous Close1.220
Day's Range1.200 - 1.240
52-Week Range1.160 - 1.420
Betan/a
RSI46.11
Earnings DateMar 30, 2026

About FRA:S1R

Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as in... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1994
Employees 49,402
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol S1R

Financial Performance

In 2024, FRA:S1R's revenue was 275.25 billion, an increase of 5.75% compared to the previous year's 260.30 billion. Earnings were 4.55 billion, an increase of 20.82%.

Financial numbers in CNY Financial Statements